Steve Thorne - Brainchip Holdings Vice Sales
| BRN Stock | 0.32 0.02 6.67% |
Executive
Steve Thorne is Vice Sales of Brainchip Holdings
| Address | 210 George Street, Sydney, NSW, Australia, 2000 |
| Phone | 61 2 9290 9606 |
| Web | https://brainchip.com |
Brainchip Holdings Management Efficiency
The company has return on total asset (ROA) of (0.6396) % which means that it has lost $0.6396 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.2332) %, meaning that it generated substantial loss on money invested by shareholders. Brainchip Holdings' management efficiency ratios could be used to measure how well Brainchip Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Brainchip Holdings' Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 274.5 K in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 14.8 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| CPA BAcc | Apiam Animal Health | N/A | |
| Morgan Bryant | Viva Leisure | N/A | |
| LLM FCIS | Apiam Animal Health | N/A | |
| Aidan Kelleher | Microequities Asset Management | N/A | |
| Tanya Watt | Retail Food Group | N/A | |
| Bronwyn Powell | Retail Food Group | N/A | |
| Angelo Konstantinou | Viva Leisure | N/A | |
| Imtiaz Bhayat | Regis Healthcare | N/A | |
| Ryan Chellingworth | Retail Food Group | N/A | |
| Gordon Martin | Viva Leisure | N/A | |
| Robert Shore | Retail Food Group | N/A | |
| Damian Zammit | Retail Food Group | N/A | |
| AGIA BA | Apiam Animal Health | N/A | |
| Tom Elliott | Retail Food Group | N/A | |
| Duncan Runciman | Apiam Animal Health | N/A | |
| Roger MAusIMM | Centaurus Metals | N/A | |
| Jodie Haydon | Regis Healthcare | N/A | |
| Michael Horwood | Regis Healthcare | N/A | |
| Sean Hodges | Viva Leisure | N/A | |
| PMP MSc | Centaurus Metals | 45 | |
| Carolyn Noumertzis | Regis Healthcare | N/A | |
Management Performance
| Return On Equity | -1.23 | ||||
| Return On Asset | -0.64 |
Brainchip Holdings Leadership Team
Elected by the shareholders, the Brainchip Holdings' board of directors comprises two types of representatives: Brainchip Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainchip. The board's role is to monitor Brainchip Holdings' management team and ensure that shareholders' interests are well served. Brainchip Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainchip Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, MD CEO | ||
| Chris Stevens, VP Sales | ||
| Sean Hehir, MD CEO | ||
| Tony Dawe, Manager Relations | ||
| Anthony Lewis, Chief Officer | ||
| Peter Made, Member Director | ||
| Kim Clark, Company Secretary | ||
| Steven Brightfield, Chief Officer | ||
| Peter MSc, Member Founder | ||
| Nandan Nayampally, Chief Officer | ||
| Anil Mankar, Co Officer | ||
| Steve Thorne, Vice Sales | ||
| Kim Larkin, Company Secretary | ||
| Ken Scarince, Chief Officer |
Brainchip Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainchip Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.23 | ||||
| Return On Asset | -0.64 | ||||
| Operating Margin | (108.93) % | ||||
| Current Valuation | 637.74 M | ||||
| Shares Outstanding | 2.07 B | ||||
| Shares Owned By Insiders | 15.82 % | ||||
| Shares Owned By Institutions | 5.97 % | ||||
| Price To Book | 28.11 X | ||||
| Price To Sales | 2,927 X | ||||
| Revenue | 232 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Brainchip Stock Analysis
When running Brainchip Holdings' price analysis, check to measure Brainchip Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainchip Holdings is operating at the current time. Most of Brainchip Holdings' value examination focuses on studying past and present price action to predict the probability of Brainchip Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainchip Holdings' price. Additionally, you may evaluate how the addition of Brainchip Holdings to your portfolios can decrease your overall portfolio volatility.